A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Egyptian Biomedical Research Network
Fraser Health
Chinese University of Hong Kong
UroGen Pharma Ltd.
UroGen Pharma Ltd.
Merck Sharp & Dohme LLC